CTLA4 and neoplasm: ,43 Given the immunological effects achieved by isoform-specific targeting of sCTLA-4, it is feasible that the anti-tumor activity of conventional pan-CTLA-4 antibodies occurs at least in part through blockade of sCTLA-4.